Abstract
Background:
Accurate neck staging is essential for performing appropriate surgery and avoiding undue morbidity in thyroid cancer. The modality of choice for evaluation is ultrasonography (US), which has limitations, particularly in the central compartment, that can be overcome by adding a computed tomography (CT).
Methods:
A total of 314 nodal levels were analyzed in 43 patients with CT, and US; evaluations were done between January 2013 and November 2015. The images were reviewed by two radiologists independently who were blinded to histopathological outcomes. The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy of US, CT, and US + CT were calculated using histology as the gold standard.
Results:
The overall sensitivity, specificity, PPV, and NPV for US, CT, and US + CT were 53.9%, 88.8%, 74.1%, and 76.4%; 81.2%, 68.0%, 60.1%, and 85.9%; and 84.6%, 66.0%, 59.6%, and 87.8%, respectively. The overall accuracy of the US was 75.80%, the CT scan was 72.93%, and the US + CT scan was 72.93%. For the lateral compartment, the sensitivity, specificity, PPV, and NPV for the US, CT, and US + CT were 56.6%, 91.4%, 77.1%, and 80.5%; 80.7%, 70.6%, 58.3%, and 87.8%; and 84.3%, 68.7%, 57.9%, and 89.6%, respectively. The accuracy of the US was 79.67%, the CT scan was 73.98%, and the US + CT scan was 73.98% for the lateral compartment. For the central compartment, the sensitivity, specificity, PPV, and NPV for the US, CT, and US + CT were 47.1%, 76.5%, 66.7%, and 59.1%; 82.4%, 55.9%, 65.1%, and 76.0%; and 85.3%, 52.9%, 64.4%, and 78.3%, respectively. The accuracy of the US was 61.76%, the CT scan was 69.12%, and the US + CT scan was 69.12% for the central compartment.
Conclusions:
This study demonstrated that CT has higher sensitivity in detecting nodal metastasis; however, its role is complementary to US due to low specificity.
Introduction
Well-differentiated thyroid cancers (WDTC) have high survival rates, and avoiding morbidity is of utmost importance in these patients. Thyroid surgery is intricate, and the outcomes vary according to the experience of the surgeons and the volume of the surgical center (1). Appropriate surgical management is essential for achieving a high cure rate and avoiding unnecessary morbidity. The extent of both central and lateral neck dissection is a matter of debate. Although global guidelines recommend therapeutic neck dissection for patients with confirmed regional metastasis (2–4), there is still no consensus on prophylactic neck dissection (Table 1) (5–12). Table 1 presents a summary of the meta-analyses on central compartment lymph node dissection. The regional recurrence is one of the most important factors that warrant thyroid carcinoma re-surgery. The incidence of regional recurrence has been reported to range from 3% to 35% (13–17). Re-surgery is associated with higher morbidity (18–20). The proponents of prophylactic neck dissection suggest that it not only decreases recurrence, hence avoiding the morbidity associated with re-surgery, but also helps in accurate staging. However, others propose that performing unnecessary neck dissection is associated with morbidity in the form of recurrent laryngeal nerve paralysis and hypoparathyroidism. Morbidity in this cancer with an excellent outcome is not acceptable. Therefore, it is essential to assess the nodes correctly. Clinical examination has low sensitivity as metastatic nodes can be sub-centimetric, and areas such as the central compartment are not amenable to meticulous palpation. Therefore, imaging plays a pivotal role in the accurate assessment of the neck nodes of patients.
Table 1
| Meta-analysis | Survival outcomes | Morbidity | Conclusion |
|---|---|---|---|
| Chisholm et al. (2009) (5) | — | Higher rate of temporary hypocalcemia | No increase in permanent morbidity |
| Zetoune et al. (2010) (6) | CND does not reduce the recurrence | — | No benefit over TT |
| Shan et al. (2012) (7) | Identical locoregional recurrence rate | Temporary hypocalcemia with CND | TT results in less surgical morbidity |
| Lang et al. (2013) (8) | Reduced risk of LRR | Higher temporary hypocalcemia | LRR risk reduction could be due to high RAI ablation or selection bias |
| Wang et al. (2013) (9) | Trend toward lower recurrence | No difference in long-term complication | Safe in high-volume centers |
| Zhao et al. (2017) (10) | Significantly reduces locoregional recurrence in the central compartment but no significant difference in the lateral compartment | Significantly higher odds of temporary hypocalcemia, permanent hypocalcemia, and increased overall morbidity | Lesser locoregional recurrence but an increased rate of hypocalcemia |
| Hughes et al. (2018) (11) | Effect on locoregional recurrence rates uncertain | Permanent hypoparathyroidism is more common but no significant difference in RLN palsy rates | May change the postoperative adjuvant RAI treatment |
| Liu et al. (2019) (12) | Overall recurrence is significantly lower; lower for the central compartment but not for the lateral compartment | — | Reduction in the risk of recurrence Prevents central compartment recurrence |
Meta-analyses comparing outcomes of central compartment clearance.
CND, prophylactic central neck dissection; TT, total thyroidectomy; LRR, locoregional recurrence; RAI, radioactive iodine.
The most accepted and recommended imaging modality worldwide is ultrasound (US). However, it has certain limitations, such that it is operator dependent, cannot be used to image mediastinal and retropharyngeal nodes, which may have a high incidence of metastasis in thyroid cancer. The diagnostic accuracy is poor in assessing even the central compartment due to the anatomical location and overlying thyroid gland. A recently published meta-analysis of 19 studies with over 4,000 patients showed that the US pooled sensitivity and area under the curve (AUC) in assessing central compartment nodes were 0.33 and 0.69, respectively, compared with those in the lateral compartment, which were 0.70 and 0.88, respectively (21).
Attempts have been made to assess the accuracy of various cross-sectional imaging (22–24). However, the limitations of these modalities include low sensitivity, high cost, and precarious availability. A recently published meta-analysis of 38 articles with 6,285 patients compared 12 modalities, namely, US, computed tomography (CT), US + CT, contrast-enhanced US (CEUS), magnetic resonance diffusion tensor imaging (MRI), F-18 fluorodeoxyglucose positron emission tomography/CT (PET/CT), 131I whole-body (IWBC), US + CEU, strain elastography (SE-US), fine-needle aspiration thyroglobulin (FNA-Tg), US-guided fine-needle aspiration cytology (FNAC), and FNAC–FNA-Tg. The results showed that the sensitivity was highest for US + CT, and the specificity was highest for FNAC (25). Research has been directed to evaluate the role of contrast-enhanced CT (CECT) in assessing neck nodes (26–28). The advantages of CECT are its accessibility and availability of acquired images for interpretation. Moreover, it provides detailed anatomical location of the disease with respect to the surrounding landmark structures. However, it has limited accuracy in evaluating small thyroid nodules. The current American Thyroid Association guidelines recommend performing CECT in the presence of clinically bulky neck nodes and locally advanced thyroid cancers (3). The role in the routine assessment of all differentiated thyroid cancers remains unclear. We conducted a study at our center to evaluate the incremental value of CT to the US in detecting nodal metastasis in WDTC.
Materials and methods
The institutional ethics committee approved this study, and the electronic medical records of 926 patients who underwent surgery at our center between 1 January 2013 and 30 November 2015 were retrieved. The final analysis was performed on 43 patients with 314 lymph nodal levels, who had both CT and US prior to surgery and whose level-wise lymph node histology was available. Two radiologists AM and NS reviewed the images independently while being blinded to the histopathological findings. The majority of the surgeries were performed by a single surgeon (AKD) who was assisted by a lead author (RV), and level-wise sampling of the nodes was performed in a standardized manner. The level-wise nodes were sent in separate packets for histopathological examination. The surgical and radiological findings were recorded and corroborated by a single investigator (RV) in a pre-specified proforma to maintain uniformity. Patient demographics were extracted from the electronic medical records, such as age, gender, clinical examination, FNAC, previous treatment, and surgical extent.
Ultrasonography
US was performed on GE Voluson E8 with linear transducer at 7–18 MHz. Both the lateral and central compartments defined according to the AJCC were assessed. The central compartment (level VI) was scanned from the submental area to the sternal notch. The lateral compartment (levels II–IV) was scanned from the mandible to the clavicle and the posterior compartment (level V) along the posterior border of the sternocleidomastoid to the anterior border of the trapezius muscle. The following features were documented to differentiate between the metastatic and benign node: loss of fatty hilum, hypoechogenicity, cystic or necrotic changes, calcification, and size >5 mm in short-axis diameter with a rounded shape. The radiologist interpreting the US findings was blinded to the CT findings.
Computed tomography
All patients underwent CT scans using the 16-slice multidetector CT scanner (Somatom Sensation 16, Siemens Healthcare). Unenhanced and enhanced scans were obtained for reconstruction slice thickness of 3 mm in axial and coronal images. The slices were acquired at 3 mm thickness and reconstructed at 0.75 mm thickness. The contrast-enhanced scans were obtained after injecting 50–90 ml of an iodinated non-ionic contrast agent at 1.8 ml/s using an automated injector with a scan delay time of 45 s. The scans were assessed on special BARCO Monitors (Barco Electronic Systems Pvt. Ltd.), wherein multiplanar reformations were obtained (to view images in the sagittal and coronal planes). The contrast-enhanced scans were obtained 45 s after intravenous contrast injection, which was the late arterial/early venous phase. The following criteria were documented to detect malignancy: strong enhancement without hilar vessel enhancement, heterogeneous enhancement, calcification, and cystic or necrotic changes. The radiologist analyzing the CT scan was blinded to the US findings.
The image interpretation is shown in Figure 1.
Figure 1
• Benign: the absence of any suspicious feature.
• Indeterminate: the presence of any suspicious feature.
• Metastatic: the presence of two or more suspicious features.
The scans were reviewed by two radiologists independently, namely, AM and NS, and were reviewed and discussed together if there was a discrepancy in opinion.
Surgery
Surgery was performed according to the standard protocol. Central compartment clearance was performed from the hyoid to the innominate artery and laterally up to the carotid sheaths. For selective neck dissection, levels II, III, and IV were sampled and sent for a frozen section. If metastasis was reported at levels II-IV on frozen section then level V clearance was also done. In addition, the patients with nodal metastasis confirmed by FNAC underwent level II–V clearance up front. The level-wise nodes were sent in separate packets for histopathology evaluation.
Histopathology
For the histopathological examination, the nodes less than 1 cm were embedded in whole, and a single section was studied; the nodes measuring 1–2.5 cm were bisected along the long axis with both halves submitted for examination, those larger than 2.5 cm were sectioned serially, and a minimum of two sections were studied.
Statistical considerations
The data were entered and analyzed using SPSS version 20. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of US alone, CT alone, and both in predicting level-wise nodal metastasis were calculated for the overall, lateral and central compartments. The histopathology report was taken as the gold standard for comparison. The McNemar test was performed to compare the sensitivity and specificity; a p-value < 0.05 was considered significant.
Results
Demography
A total of 43 patients were analyzed in this study, of whom 27 were females and 16 were males. The mean age was 40.79 (12–79) years. FNAC was performed on 41 patients. It was suggestive of papillary carcinoma (TBS VI) in 32 patients and suspicious of papillary (TBS V) carcinoma in nine patients. A slide review of previous surgery in the remaining two patients showed papillary carcinoma. In total, 17 patients were clinically node-positive in the lateral neck. Central compartment nodes were not palpable in any patient.
Surgery
A total of 40 patients underwent surgery for thyroid primary, and three patients underwent only neck dissection. For thyroid primary, 35 total and five completion thyroidectomies were performed. In addition, 39 patients underwent central compartment clearance, of whom 31 underwent bilateral neck dissection, four underwent right-sided neck dissection, and four underwent left-sided neck dissection. Furthermore, 43 patients underwent lateral neck dissection, of whom 31 were bilateral, four were right selective neck dissections, and eight were left selective neck dissections. Preoperative cords were bilaterally mobile in 36 patients, six patients had right-side impairment or palsy, and one patient had left-side impairment or palsy.
Imaging and histopathology
A total of 516 nodal levels were analyzed in the US and CT. Histopathology was available for 314 nodal levels. Of the 314 nodes, 117 showed metastasis, and 197 were benign. US impression was malignant in 85 levels and benign in 229 levels. CT impression was malignant in 158 levels and benign in 156 levels. US + CT impression was malignant in 166 levels and benign in 148 levels. US, CT, and US + CT correctly diagnosed 63, 95, and 99 metastatic nodal levels.
Histopathology
A total of 314 nodal levels were reported on histopathology. Overall, regional metastasis was present in 31/43 (72.1%) patients. In the lateral and central compartments, 25/43 (58.1%) and 24/39 (61.5%) patients had metastatic nodes, respectively.
Overall
The sensitivity of CT was significantly higher than that in US, i.e., 81.20% and 53.85%, respectively (p < 0.001). The sensitivity of US + CT was significantly higher than that in US alone, i.e., 84.62% and 53.85%, respectively (p < 0.001). However, the difference between the sensitivity of CT and US + CT was not statistically significant (p = 0.125).
The specificity of US was significantly higher than that of CT, i.e., 88.83% and 68.02%, respectively (p < 0.001). The specificity of US was higher compared with that of US + CT, 88.83% and 65.99%, respectively (p < 0.001). The difference between the specificity of CT and US + CT was not statistically significant (p = 0.125) (Table 2).
Table 2
| Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
|---|---|---|---|---|
| US | 53.85 | 88.83 | 74.12 | 76.42 |
| CT | 81.20 | 68.02 | 60.13 | 85.90 |
| US + CT | 84.62 | 65.99 | 59.64 | 87.84 |
Sensitivity, specificity, NPV, and PPV of US, CT, and US + CT in the overall assessment of lymph node metastasis.
The accuracy of the US was 75.80%, the CT scan was 72.93%, and the US + CT scan was 72.93%.
Lateral compartment
The sensitivity of CT was significantly higher than that of US, 80.72% and 56.63%, respectively (p < 0.001). The sensitivity of US + CT was significantly higher than that of US alone, 84.34% and 56.63%, respectively (p < 0.001). However, the difference between the sensitivity of CT and US + CT was not statistically significant (p = 0.25).
The specificity of the US was significantly higher than that of CT, 91.41% and 70.55%, respectively (p < 0.001). The specificity of US was higher compared with that of US + CT, 91.41% and 68.71%, respectively (p < 0.001). The difference between the specificity of CT and US + CT was not statistically significant (p = 0.25) (Table 3).
Table 3
| Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
|---|---|---|---|---|
| US | 56.63 | 91.41 | 77.05 | 80.54 |
| CT | 80.72 | 70.55 | 58.26 | 87.79 |
| US + CT | 84.34 | 68.71 | 57.85 | 89.60 |
Sensitivity, specificity, NPV, and PPV of US, CT, and US + CT in the assessment of lateral compartment lymph node metastasis.
The accuracy of the US was 79.67%, the CT scan was 73.98%, and the US + CT scan was 73.98%.
Central compartment
The sensitivity of CT was significantly higher than that of US, 82.35% and 47.06%, respectively (p < 0.001). The sensitivity of US + CT was significantly higher than that of US alone, 85.29% and 47.06%, respectively (p < 0.001). However, the difference between the sensitivity of CT and US + CT was not statistically significant (p = 1).
The specificity of the US was significantly higher than that of CT, 76.47% and 55.88%, respectively (p = 0.039). The specificity of US was higher compared with that of US + CT, 76.47% and 52.94%, respectively (p < 0.01). The difference between the specificity of CT and US + CT was not statistically significant (p = 1) (Table 4). The accuracy of the US was 61.76%, the CT scan was 69.12%, and the US + CT scan was 69.12%.
Table 4
| Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
|---|---|---|---|---|
| US | 47.06 | 76.47 | 66.67 | 59.09 |
| CT | 82.35 | 55.88 | 65.12 | 76.00 |
| US + CT | 85.29 | 52.94 | 64.44 | 78.26 |
Sensitivity, specificity, NPV, and PPV of US, CT, and US + CT scan in the assessment of central compartment lymph node metastasis.
The specificity of US, CT, and US + CT was higher for the lateral compartment than for the central compartment.
Follow-up and disease outcomes
At the median follow-up of 59 (0.03–106) months, eight patients had disease recurrence. Two patients had nodal recurrence, one patient had locoregional recurrence, one patient had nodal recurrence with skin nodule, and four patients had distant metastasis. At the last follow-up, 36 patients were alive and disease-free, six patients were alive with disease, and one patient was dead due to an unknown cause.
Discussion
The incidence of regional metastasis in papillary thyroid cancer has been reported as 30%–84% (29–32). The first echelon of drainage is the central compartment. The incidence of occult metastasis in the central compartment ranges from 37% to 41% (33, 34). The incidence of metastasis, even in microcarcinoma, has been reported to be 64.1% in the central compartment and 44.5% in the lateral compartment (35). The overall incidence of nodal metastasis in our study was 72.1%. The incidence of the central and lateral compartments was 61.5% and 58.1%, respectively.
US is the initial modality for the assessment of regional metastasis. The sensitivity of the US reported in the literature is approximately 46%–92%. The sensitivity for the central compartment is lower than that for the lateral compartment. The specificity ranges between 73% and 100% (36–40). The probability of missing the disease is high in the US due to low sensitivity. In our study, the overall sensitivity, specificity, PPV, and NPV of the US were 53.85%, 88.83%, 74.12%, and 76.42%, respectively. The sensitivity, specificity, PPV, and NPV were 56.63%, 91.41%, 77.05%, and 80.54% for the lateral compartment and 47.06%, 76.47%, 66.67%, and 59.09% for the central compartment, respectively (Tables 2–4).
There are various reasons for the low sensitivity of the US. First, US features considered have varied accuracy in predicting the nature of the node (41, 42). Size as an isolated criterion has lower accuracy compared with microcalcification and necrosis. Unlike squamous cell carcinoma, even a sub-centimeter node can harbor metastasis in the case of papillary thyroid cancer (32). Second, the US is observer-dependent, and studies have shown that there exists a significant inter-observer variation (43). More experienced sonologists or surgeons have higher accuracy in detecting nodal disease than someone working in low-volume centers with limited experience. Third, the US has a technical limitation in assessing the central compartment nodes (44). The presence of overlying thyroid, clavicle, and sternocleidomastoid decreases the sensitivity of the US in detecting central compartment metastasis. In addition, certain areas such as the parapharyngeal and mediastinal nodes are not accessible for US examination. Although we have not compared US with CT scan for mediastinal and parapharyngeal nodes in our study, the US has low sensitivity by design due to penetration limitations and shadowing from the clavicle, lung air spaces, and thyroid gland.
The CT scan has the advantage of being objective and images available for interpretation. It overcomes the limitation of the US in assessing the central compartment. It is also helpful in imaging nodes in the upper thorax, which are difficult to examine in the US and are routinely missed. Studies have compared the sensitivity and specificity of the US with CT scans. The sensitivity in most studies is reported to be higher for CT scans. This difference is specially marked for the central compartment. However, the results on specificity are inconsistent (27, 45–54). High sensitivity makes CT an excellent screening tool for detecting regional metastasis. The overall sensitivity, specificity, PPV, and NPV of the CT scan were 81.20%, 68.02%, 60.13%, and 85.90%, respectively. The sensitivity, specificity, PPV, and NPV were 80.72%, 70.55%, 58.26%, and 87.79% for the lateral compartment and 82.35%, 55.88%, 65.12%, and 76.00% for the central compartment, respectively (Tables 2–4). The limitation of CT scans is the low specificity. High false-positive results may over-stage the disease and result in unwarranted neck dissection.
The issue with a CT scan that constrains its use in thyroid carcinoma assessment is the administration of iodinated contrast. It is often presumed that it may affect the efficacy of radioiodine ablation in the postoperative period by hindering its entrapment by the thyroid. It has been shown that urine iodine excretion 1 month after the preoperative CT scan is the same as that 6 months after the scan, challenging the concept of delaying the radioactive iodine (RAI) for 3–4 months after the scan (45, 55). Second, the role of RAI is limited in low and intermediate-risk patients. It can be safely avoided in patients with small primaries < 1 cm and micrometastasis in nodes <5 in number without other high-risk features. Therefore, a CT scan can be done in most patients without affecting the radioactive iodine ablation efficacy as it is either not warranted or has no proven survival benefit. A CT scan can, therefore, be used for imaging these cancers. An established role is in high-risk patients with extrathyroidal extension, >4 cm in size, and large nodal metastasis. In locally advanced cancer, a CT scan is the modality of choice for disease assessment, precluding this argument in these cases (2, 3).
The highest sensitivity in the literature is reported with the US + CT combination (Table 5) (27, 45, 47, 48, 50, 52, 56). Therefore, the combination is best to assess both the lateral and central neck for metastasis. In our study, the sensitivity was highest for combined US + CT for the overall, lateral and central compartments, 84.62%, 84.34%, and 85.29%, respectively. A recently published meta-analysis of 11 studies with 6,261 thyroid cancer patients reported the diagnostic accuracy of US + CT in assessing neck node metastasis. The sensitivity and specificity to detect central compartment metastasis were 0.57 and 0.82, respectively; 0.89 and 0.79, respectively, for the lateral compartment; and 0.73 and 0.80, respectively, for all compartments (57).
Table 5
| Number (n) | Overall | Central compartment | Lateral compartment | ||||
|---|---|---|---|---|---|---|---|
| Sensitivity | Specificity | Sensitivity | Specificity | Sensitivity | Specificity | ||
| Kim et al. (2008) (27) | 165 patients | US + CT | Similar for US and CT higher than US + CT | US + CT | Similar for US and CT higher than US + CT | US + CT | US + CT similar to US and lower than CT |
| Lesnik et al. (2014) (45) | 162 patients | — | — | CT better than US, highest for US + CT | US and CT comparable and higher than US + CT | US and CT similar and highest for US + CT | US and CT comparable and higher than US + CT |
| Yoon et al. (2011) (46) | 122 lateral cervical lymph nodes of 113 patients | — | — | — | — | US + CT | US |
| Lee et al. (2013) (47) | 252 patients | US + CT | US | US + CT | US | US + CT | US |
| Choi et al. (2009) (48) | 299 patients | — | — | highest for US + CT | Similar for US and CT higher than US + CT | Highest US + CT Comparable to US | CT |
| Ahn et al. (2008) (49) | 37 patients | CT | US | CT | US | CT | US |
| Kim et al. 2017 (50) | 6,577 central neck levels 3,668 PTC patients | — | — | CT + US | US | — | — |
| Choi et al. (2010) (51) | 589 patients | CT | CT marginally higher than | US | CT marginally higher | CT | US marginally higher |
| Suh et al. (2017) (52) | 1,691 patients | US + CT | US | US + CT similar to CT | US | US + CT | CT |
| Xing et al. (2020) (53) | 5,656 patients | CT higher than US | US higher than CT | CT higher than US | US higher than CT | CT higher than US | US higher than CT |
| Yang et al. (2022) (56) | 11,601 lymph nodes | US + CT | US | US + CT | US | US + CT | US |
| Alabousi et al. (2022) (54) | 12,771 lymph nodes | US and CT similar | US and CT similar | CT higher than US | US higher than CT | US and CT similar | US and CT similar |
| Albuck et al. (2023) (58) | 15,014 lymph nodes | CT + US better | US better | CT and CT + US similar and better than US | CT and US similar and slightly higher than CT + US | CT + US better than CT or US alone | CT greater than US and CT + US |
Studies comparing the sensitivity and specificity of US, CT, and US + CT in assessing overall, central and lateral compartments in thyroid cancers.
Our center is a tertiary cancer center, and we perform more than 300–350 thyroid surgeries in a year. The strength of this study is that the image analysis is done by a group of radiologists with adequate experience in thyroid imaging at a high-volume center. Most surgeries were performed by a single senior surgeon and assisted by the candidate in a standardized manner after studying the images with radiologists. The study provides a level-wise assessment of the two imaging modalities and their combination, which has been compared with the histopathology in all patients. In addition to the correlation with the histopathology, the study also provides a long-term follow-up of the patients who have undergone surgery, which is not provided in most other similar studies. A small number of patients is the limitation of the study as a CT scan is not performed in all the patients who undergo surgery for early disease.
Although the high sensitivity of CT scans makes it an ideal imaging for screening, the low specificity is the obvious limitation. US with high specificity and low sensitivity is likely to miss metastatic nodes, especially in the central compartment. Therefore, neither of the imaging modalities alone is good enough to assess the neck.
Therefore, we conclude that the sensitivity of CT and US + CT was significantly higher than the US in detecting the overall, lateral compartment and central compartment regional metastasis. The specificity of US was significantly higher compared with CT and US + CT in detecting the overall, lateral compartment and central compartment regional metastasis. The role of US and CT scans is complementary in assessing neck node metastasis. However, a large numbered prospective study is needed to accurately determine the role of these imaging modalities in WDTC.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by the Institutional Ethics Committee of Tata Memorial Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The Ethics Committee/institutional review board waived the requirement of written informed consent for participation from the participants or the legal guardians/next of kin of the participants because it is a retrospective study reviewing the images and reports on PACS and electronic medical records. There was no direct contact with the patient and no intervention in the study.
Author contributions
RV: study concept, study design, data collection, data interpretation, drafting the manuscript, reviewing the manuscript, and finalizing. RV agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. AM: study concept, study design, image analysis, data collection, data interpretation, drafting the manuscript, reviewing the manuscript, and finalizing. NS: image analysis, data collection, drafting the manuscript, reviewing the manuscript, and finalizing. RD: statistical analysis. AD: drafting the manuscript, reviewing the manuscript, and finalizing. MB: drafting the manuscript, reviewing the manuscript, and finalizing. AKD: study concept, study design, drafting the manuscript, reviewing the manuscript, and finalizing. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author AM declared that he was an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
SosaJABowmanHMTielschJMPoweNRGordonTAUdelsmanR. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. (1998) 228(3):320–30. 10.1097/00000658-199809000-00005
2.
PerrosPBoelaertKColleySEvansCEvansRMGerrard BaGet alGuidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). (2014) 81(Suppl 1):1–122. 10.1111/cen.12515
3.
HaugenBRAlexanderEKBibleKCDohertyGMMandelSJNikiforovYEet al2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. (2016) 26(1):1–133. 10.1089/thy.2015.0020
4.
National Comprehensive Cancer Network clinical practice guidelines in oncology (NCCN guidelines): thyroid cancer, version 4. (2023). Available at:https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf (Accessed October 15, 2023).
5.
ChisholmEJKulinskayaETolleyNS. Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope. (2009) 119(6):1135–9. 10.1002/lary.20236
6.
ZetouneTKeutgenXBuitragoDAldailamiHShaoHMazumdarMet alProphylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol. (2010) 17(12):3287–93. 10.1245/s10434-010-1137-6
7.
ShanCXZhangWJiangDZZhengXMLiuSQiuM. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope. (2012) 122(4):797–804. 10.1002/lary.22162
8.
LangBHHNgSHLauLLHCowlingBJWongKPWanKY. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid. (2013) 23(9):1087–98. 10.1089/thy.2012.0608
9.
WangTSCheungKFarrokhyarFRomanSASosaJA. A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. Ann Surg Oncol. (2013) 20(11):3477–83. 10.1245/s10434-013-3125-0
10.
ZhaoWYouLHouXChenSRenXChenGet alThe effect of prophylactic central neck dissection on locoregional recurrence in papillary thyroid cancer after total thyroidectomy: a systematic review and meta-analysis: PCND for the locoregional recurrence of papillary thyroid cancer. Ann Surg Oncol. (2017) 24(8):2189–98. 10.1245/s10434-016-5691-4
11.
HughesDTRosenJEEvansDBGrubbsEWangTSSolórzanoCC. Prophylactic central compartment neck dissection in papillary thyroid cancer and effect on locoregional recurrence. Ann Surg Oncol. (2018) 25(9):2526–34. 10.1245/s10434-018-6528-0
12.
LiuHLiYMaoY. Local lymph node recurrence after central neck dissection in papillary thyroid cancers: a meta analysis. Eur Ann Otorhinolaryngol Head Neck Dis. (2019) 136(6):481–7. 10.1016/j.anorl.2018.07.010
13.
SimonDGoretzkiPEWitteJRöherHD. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg. (1996) 20(7):860–6; discussion 866. 10.1007/s002689900131
14.
ConzoGMaurielloCDocimoGGambardellaCThomasGCavalloFet alClinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery. Int J Surg Lond Engl. (2014) 12(Suppl 1):S194–197. 10.1016/j.ijsu.2014.05.010
15.
ConzoGPasqualiDBellastellaGEspositoKCarellaCDe BellisAet alTotal thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine. (2013) 44(2):419–25. 10.1007/s12020-013-9877-2
16.
ItoYKudoTTakamuraYKobayashiKMiyaAMiyauchiA. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection. World J Surg. (2012) 36(3):593–7. 10.1007/s00268-011-1391-1
17.
ConzoGDocimoGPasqualiDMaurielloCGambardellaCEspositoDet alPredictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study. BMC Surg. (2013) 13(Suppl 2):S3. 10.1186/1471-2482-13-S2-S3
18.
ToniatoABoschinIMPiottoAPelizzoMRGuoloAFolettoMet alComplications in thyroid surgery for carcinoma: one institution’s surgical experience. World J Surg. (2008) 32(4):572–5. 10.1007/s00268-007-9362-2
19.
RohJLKimJMParkCI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann Surg Oncol. (2011) 18(5):1312–8. 10.1245/s10434-010-1470-9
20.
LefevreJHTresalletCLeenhardtLJublancCChigotJPMenegauxF. Reoperative surgery for thyroid disease. Langenbecks Arch Surg Dtsch Ges Für Chir. (2007) 392(6):685–91. 10.1007/s00423-007-0201-6
21.
ZhaoHLiH. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases. Eur J Radiol. (2019) 112:14–21. 10.1016/j.ejrad.2019.01.006
22.
KingADAhujaATToEWHTseGMKMetreweliC. Staging papillary carcinoma of the thyroid: magnetic resonance imaging vs ultrasound of the neck. Clin Radiol. (2000) 55(3):222–6. 10.1053/crad.1999.0373
23.
LiuZXunXWangYMeiLHeLZengWet alMRI and ultrasonography detection of cervical lymph node metastases in differentiated thyroid carcinoma before reoperation. Am J Transl Res. (2014) 6(2):147–54. PMID: ; PMCID: PMC3902225.
24.
ChoiWHChungYAHanEJSohnHSLeeSH. Clinical value of integrated [18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the preoperative assessment of papillary thyroid carcinoma: comparison with sonography. J Ultrasound Med. (2011) 30(9):1267–73. 10.7863/jum.2011.30.9.1267
25.
WangSRLiQLTianFLiJLiWXChenMet alDiagnostic value of multiple diagnostic methods for lymph node metastases of papillary thyroid carcinoma: a systematic review and meta-analysis. Front Oncol. (2022) 12:990603. 10.3389/fonc.2022.990603
26.
SolerZMHamiltonBESchuffKGSamuelsMHCohenJI. Utility of computed tomography in the detection of subclinical nodal disease in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. (2008) 134(9):973–8. 10.1001/archotol.134.9.973
27.
KimEParkJSSonKRKimJHJeonSJNaDG. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid. (2008) 18(4):411–8. 10.1089/thy.2007.0269
28.
ChoSJSuhCHBaekJHChungSRChoiYJLeeJH. Diagnostic performance of CT in detection of metastatic cervical lymph nodes in patients with thyroid cancer: a systematic review and meta-analysis. Eur Radiol. (2019) 29(9):4635–47. 10.1007/s00330-019-06036-8
29.
PereiraJAJimenoJMiquelJIglesiasMMunnéASanchoJJet alNodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery. (2005) 138(6):1095–100; discussion 1100–1. 10.1016/j.surg.2005.09.013
30.
BonnetSHartlDLeboulleuxSBaudinELumbrosoJDAl GhuzlanAet alProphylactic lymph node dissection for papillary thyroid cancer less than 2cm: implications for radioiodine treatment. J Clin Endocrinol Metab. (2009) 94(4):1162–7. 10.1210/jc.2008-1931
31.
MachensAHinzeRThomuschODralleH. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. (2002) 26(1):22–8. 10.1007/s00268-001-0176-3
32.
NoguchiMYamadaHOhtaNIshidaTTajiriKFujiiHet alRegional lymph node metastases in well-differentiated thyroid carcinoma. Int Surg. (1987) 72(2):100–3. PMID: .
33.
ZhangLYLiuZWLiuYWGaoWSZhengCJ. Risk factors for nodal metastasis in cN0 papillary thyroid microcarcinoma. Asian Pac J Cancer Prev APJCP. (2015) 16(8):3361–3. 10.7314/APJCP.2015.16.8.3361
34.
SoYKSonYIHongSDSeoMYBaekCHJeongHSet alSubclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery. (2010) 148(3):526–31. 10.1016/j.surg.2010.01.003
35.
WadaNDuhQYSuginoKIwasakiHKameyamaKMimuraTet alLymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. (2003) 237(3):399–407. 10.1097/01.SLA.0000055273.58908.19
36.
WuLMGuHYQuXHZhengJZhangWYinYet alThe accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: a meta-analysis. Eur J Radiol. (2012) 81(8):1798–805. 10.1016/j.ejrad.2011.04.028
37.
LeeCYSnyderSKLairmoreTCDupontSCJupiterDC. Utility of surgeon-performed ultrasound assessment of the lateral neck for metastatic papillary thyroid cancer. J Oncol. (2012) 2012:973124. 10.1155/2012/973124
38.
GonzálezHECruzFO’BrienAGoñiILeónAClaureRet alImpact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. (2007) 133(12):1258–62. 10.1001/archotol.133.12.1258
39.
RohJLParkJYKimJMSongCJ. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol. (2009) 99(1):28–31. 10.1002/jso.21164
40.
StulakJMGrantCSFarleyDRThompsonGBvan HeerdenJAHayIDet alValue of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg Chic Ill 1960. (2006) 141(5):489–94; discussion 494–6. 10.1001/archsurg.141.5.489
41.
WeiQWuDLuoHWangXZhangRLiuY. Features of lymph node metastasis of papillary thyroid carcinoma in ultrasonography and CT and the significance of their combination in the diagnosis and prognosis of lymph node metastasis. J BUON. (2018) 23(4):1041–8. PMID: .
42.
LiuZZengWLiuCWangSXiongYGuoYet alDiagnostic accuracy of ultrasonographic features for lymph node metastasis in papillary thyroid microcarcinoma: a single-center retrospective study. World J Surg Oncol. (2017) 15(1):32. 10.1186/s12957-017-1099-2
43.
MoonHJYoonJHKwakJYChungWYNamKHJeongJJet alPositive predictive value and interobserver variability of preoperative staging sonography for thyroid carcinoma. AJR Am J Roentgenol. (2011) 197(2):W324–30. 10.2214/AJR.10.5576
44.
ChoiJSChungWYKwakJYMoonHJKimMJKimEK. Staging of papillary thyroid carcinoma with ultrasonography: performance in a large series. Ann Surg Oncol. (2011) 18(13):3572–8. 10.1245/s10434-011-1783-3
45.
LesnikDCunnaneMEZurakowskiDAcarGOEcevitCMaceAet alPapillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients. Head Neck. (2014) 36(2):191–202. 10.1002/hed.23277
46.
YoonJHKimJYMoonHJYoukJHSonEJKimEKet alContribution of computed tomography to ultrasound in predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma. Ann Surg Oncol. (2011) 18(6):1734–41. 10.1245/s10434-010-1527-9
47.
LeeDWJiYBSungESParkJSLeeYJParkDWet alRoles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma. Eur J Surg Oncol. (2013) 39(2):191–6. 10.1016/j.ejso.2012.07.119
48.
ChoiJSKimJKwakJYKimMJChangHSKimEK. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am J Roentgenol. (2009) 193(3):871–8. 10.2214/AJR.09.2386
49.
AhnJELeeJHYiJSShongYKHongSJLeeDHet alDiagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J Surg. (2008) 32(7):1552–8. 10.1007/s00268-008-9588-7
50.
KimSKWooJWParkILeeJHChoeJHKimJHet alComputed tomography-detected central lymph node metastasis in ultrasonography node-negative papillary thyroid carcinoma: is it really significant?Ann Surg Oncol. (2017) 24(2):442–9. 10.1245/s10434-016-5552-1
51.
ChoiYJYunJSKookSHJungECParkYL. Clinical and imaging assessment of cervical lymph node metastasis in papillary thyroid carcinomas. World J Surg. (2010) 34(7):1494–9. 10.1007/s00268-010-0541-1
52.
SuhCHBaekJHChoiYJLeeJH. Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis. Am J Neuroradiol. (2017) 38(1):154–61. 10.3174/ajnr.A4967
53.
XingZQiuYYangQYuYLiuJFeiYet alThyroid cancer neck lymph nodes metastasis: meta-analysis of US and CT diagnosis. Eur J Radiol. (2020) 129:109103. 10.1016/j.ejrad.2020.109103
54.
AlabousiMAlabousiAAdhamSPozdnyakovARamadanSChaudhariHet alDiagnostic test accuracy of ultrasonography vs computed tomography for papillary thyroid cancer cervical lymph node metastasis: a systematic review and meta-analysis. JAMA Otolaryngol Neck Surg. (2022) 148(2):107. 10.1001/jamaoto.2021.3387
55.
SohnSYChoiJHKimNKJoungJYChoYYParkSMet alThe impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment. Thyroid. (2014) 24(5):872–7. 10.1089/thy.2013.0238
56.
YangJZhangFQiaoY. Diagnostic accuracy of ultrasound, CT and their combination in detecting cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis. BMJ Open. (2022) 12(7):e051568. 10.1136/bmjopen-2021-051568
57.
WangYChenMChenPTongJZhangYYangG. Diagnostic performance of ultrasound and computed tomography in parallel for the diagnosis of lymph node metastasis in patients with thyroid cancer: a systematic review and meta-analysis. Gland Surg. (2022) 11(7):1212–23. 10.21037/gs-22-347
58.
AlbuckALIssaPPHusseinMAboueishaMAttiaASOmarMet alA combination of computed tomography scan and ultrasound provides optimal detection of cervical lymph node metastasis in papillary thyroid carcinomas: a systematic review and meta-analysis. Head Neck. (2023) 45(9):2173–84. 10.1002/hed.27451
Summary
Keywords
thyroid cancer, lymph node metastasis, lymphatic metastasis/diagnostic imaging, ultrasonography, computed tomography
Citation
Vaish R, Mahajan A, Sable N, Dusane R, Deshmukh A, Bal M and D’cruz AK (2023) Role of computed tomography in the evaluation of regional metastasis in well-differentiated thyroid cancer. Front. Radiol. 3:1243000. doi: 10.3389/fradi.2023.1243000
Received
20 June 2023
Accepted
28 September 2023
Published
31 October 2023
Volume
3 - 2023
Edited by
Lorenzo Ugga, University of Naples Federico II, Italy
Reviewed by
Evren Üstüner, Ankara University School of Medicine, Türkiye Chiara Paolella, Università degli Studi di Napoli Federico II, Italy
Updates
Copyright
© 2023 Vaish, Mahajan, Sable, Dusane, Deshmukh, Bal and D'cruz.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Richa Vaish drvaishricha@gmail.com
†These authors share first authorship
‡ Present Addresses: Abhishek Mahajan,Department of Imaging, The ClatterbridgeCancer Centre NHS Foundation Trust,Liverpool, United Kingdom Anil K. D'Cruz,Director Oncology-Apollo Group of Hospitals, Department of Oncology, Apollo Hospital, Navi Mumbai, India
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.